Skytrofa (Lonapegsomatropin-tcgd)
- Medicine Name: Skytrofa
- Generic Name: Lonapegsomatropin-tcgd
- Dosage Form & Strength: For injection: 3mg/3.6mg/4.3mg/5.2mg/6.3mg/7.6mg/9.1mg/11mg/13.3 mg
- Manufactured By: Ascendis Pharma
Medical Uses
Skytrofa is formulated as a human growth hormone and widely used for treating pediatric patients aged 12 months and older, weighing at least 11.5kg (26 pounds), and having growth failure because of poor secretion of endogenous growth hormone (GH).
Recommended Dosage: Dosage of Skytrofa must be given subcutaneously into the buttock, abdomen, or thigh with a continuous rotation of the sites of injection. The recommended dose of skytrofa injection is 0.24 mg/kg body weight once weekly.
Administer a missed dose of Skytrofa as quickly as possible and not beyond two days after the missed dose. In order to avoid missed doses, this medicine can be taken two days prior to or two days after the scheduled dosing day. Once-weekly dosing should be resumed for the very next dose on the previously scheduled dosing day.
Warning & Precautions
- Increased mortality in all those with acute severe illness due to complications after abdominal surgery, open heart surgery, or several accidental trauma, or those with acute respiratory failure has been noted following therapy with somatropin.
- Serious systemic hypersensitivity reactions may occur with the administration of somatropin medicinal products, including Skytrofa injection. All such reactions are probable, and prompt medical attention needs to be sought in case any allergic reaction occurs.
- There is a potential for malignancy progression in those with somatropin therapy with active malignancy. Any preexisting malignancy needs to be inactive, and its treatment must be done before instituting Skytrofa therapy. Discontinue therapy in case there is evidence of recurrent malignancy.
- Evaluate all those with any known or previous history of growth hormone deficiency secondary to an intracranial neoplasm throughout the treatment with somatropin for the continuous and surge of the tumor.
- Precisely assess all those with somatropin therapy for enhanced growth or potential malignant variations of pre existing nevi. Patients should report marked changes in behavior, vision disturbances, changes in skin pigmentation, changes in the onset of headaches, and changes in the occurrence of pre-existing nevi.
- Therapy with somatropin may scale down the insulin sensitivity, mainly at higher doses. Evaluate glucose levels in all those receiving Skytrofa, mainly in those with risk factors for type-2 diabetes mellitus, such as obesity or any known family history of type-2 diabetes mellitus.
- Cases of slipped capital femoral epiphysis have been frequently noticed in patients undergoing rapid growth. Assess pediatric patients with complaints of constant hip or knee pain.
- Parathyroid hormone, alkaline phosphatase, and serum levels of phosphate may increase after therapy with somatropin. In case a patient is detected to have no normal laboratory outcomes, evaluate as required.
Documentation & Availability
What documents are required to import SKYTROFA to India?
SKYTROFA (lonapegsomatropin-tcgd) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is SKYTROFA available in India?
SKYTROFA (lonapegsomatropin-tcgd injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
SKYTROFA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of SKYTROFA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Skytrofa price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the SKYTROFA (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Skytrofa®?
Lonapegsomatropin-tcgd is a Generic Name for the trade name drug Skytrofa®.
What is the Manufacturer’s Name of Skytrofa®?
Skytrofa® is manufactured by Ascendis Pharma.
Is Skytrofa® approved by the FDA?
Yes, Skytrofa® is approved by the FDA. Date of first approval: August 25, 2021.
Where can I get Skytrofa 3.6 mg at the best price in India?
To get the best Skytrofa 3.6 mg price in India, kindly get in touch with S S Healthcare (a WHO GDP & ISO 9001:2008 certified company). For Skytrofa 3.6 mg, a valid medical prescription is required from your treating physician.
What is the dosage and form of Skytrofa® supplied?
Skytrofa® is supplied as injections: 3mg, 3.6mg, 4.3mg, 5.2mg, 6.3mg, 7.6mg, 9.1mg, 11mg, and 13.3mg for subcutaneous administration.
What are the most common side effects of Skytrofa®?
The most common side effects of Skytrofa are nausea and vomiting, viral infection, pyrexia, hemorrhage, cough, diarrhea, abdominal pain, and arthralgia and arthritis
How much does Skytrofa cost in India?
The skytrofa cost in India can vary. In order to procure this human growth hormone authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Skytrofa®?
Cartridges of Skytrofa should be refrigeratd at 36-46°F (2-8°C) in the outer carton in order to protect from light. It is not advisable to freeze this medicine.
Is it safe to buy Skytrofa® online from India?
Yes, one can buy Skytrofa from India at the best price from the S S Healthcare if Skytrofa has not been approved or is not available in your home country. We can help facilitate the supply of Skytrofa.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
